The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Just adding some Hype, so TerryMC1's narrative fits.
Feel free to add examples of why it's undervalued, or overvalued, if that's your reason for visiting a BB and posting help for those invested.
BB
A test of the 50day MA and off to a new high around first 2 weeks of July. 45-50p???
If there was a rerate on good news, who knows where it would go too - 70-90p???
Yes there could also be bad news - Just to keep TerryMC1 happy.
BB
Someone who trades with DMA ( Direct Market Access) puts in a buy order, for 100k shares. That order will appear o L2 on the sell side. If a normal access trader sells, 100k shares, the DMA will have purchased at the sell price. Every trade has a buyer and a seller.
BB
From last financial report:
'The Eastern Limb PGM supply agreements are mostly based on
the LG6 chrome reef known for its high rhodium and palladium
content, accounting for approximately 12% in the case of rhodium
and 20% in the case of palladium of a produced PGM ounce.
This compares with as low as 7% and 16% respectively of other
chrome reefs.'
BB
I don't want to join in the argument, but the WHI note is quite dated now. I'm sure the info regarding the Cobalt extraction process, still stands true. It would be nice to see an updated Broker Note to remain current on what is actually happening!
BB
207m shares issued at £0.06 = £12.42m
415m pre payment warrants paid for @ £0.0575 exercisable @ £0.0025?? = £23.8m
Then it states:
'One of the Ordinary Warrants so allotted shall entitle the holder to subscribe for one Ordinary Share at an exercise price of £0.08, and the other shall entitle the holder to subscribe for one Ordinary Share at an exercise price of £0.10.'
See below
For Ordinary Shares subscribed for under the Subscription Agreement, Armistice has agreed to pay a price of £0.06 per share. For Pre-Payment Warrants subscribed for under the Subscription Agreement, Armistice has agreed to pay a price of £0.0575 per warrant.
If the subscription obligations in the Subscription Agreement oblige the Armistice to subscribe for Ordinary Shares representing more than 9.9 per cent. of the enlarged issued share capital, Armistice will instead subscribe for Pre-Payment Warrants. Pre-Payment Warrants are exercisable at any time on payment of £0.0025.
Armistice will be allotted two Ordinary Warrants, for every one Ordinary Share or Pre-Payment Warrant that Armistice is allotted pursuant to the Subscription Agreement. One of the Ordinary Warrants so allotted shall entitle the holder to subscribe for one Ordinary Share at an exercise price of £0.08, and the other shall entitle the holder to subscribe for one Ordinary Share at an exercise price of £0.10.
Any thoughts
BB